15+ Premium newsletters by leading experts
The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
。关于这个话题，爱思助手下载最新版本提供了深入分析
В России введут ГОСТ на маникюрМастер Евгений Пятышин о ГОСТе на маникюр: Нормативы будут невыгодны бизнесу，这一点在heLLoword翻译官方下载中也有详细论述
Российский офицер назвал абсурдной задачу ВСУ форсировать Днепр08:37，推荐阅读旺商聊官方下载获取更多信息
Second, when the replication crisis hit in the early 2010s, the open science movement got a new villain—namely, naughty researchers. The fakers, the fraudsters, the over-claimers: those are the real bad boys of science. It’s no longer cool to hate international publishing conglomerates. Now it’s cool to hate your colleagues.